Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …

S arcoidosis is a systemic inflammatory disorder of unknown etiology affecting people of any
age (1, 2). The disease shows heterogeneous distribution of epithelioid granulomatous …

Cardiac involvement portends a poor prognosis in patients with sarcoidosis. However, due
to the nonspecific clinical manifestations of the disease, patchy myocardial involvement, and …

Cardiac sarcoidosis is a potentially fatal complication of sarcoidosis. The 1993 guidelines of
the Ministry of Health, Labour, and Welfare (MHLW) of Japan have been used as the …

Abstract Background The Japanese Ministry of Health and Welfare guidelines (JMHWG) are
currently the standard used to diagnose cardiac sarcoidosis. JMHWG incorporate 67 …

Background Cardiac sarcoidosis (CS) is a potentially fatal condition lacking a single test with
acceptable diagnostic accuracy. 18 F-FDG PET/CT has emerged as a promising imaging …

Sarcoidosis is a systemic granulomatous disease that forms epithelioid cell granuloma
(accompanied by infiltration of inflammatory cells) without caseous necrosis in organs …

Objective The purpose of the current study was to investigate the diagnostic performance of
F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography …

Cardiac sarcoidosis (CS) is a rare and potentially life-threatening disease that causes
conduction disturbance, systolic dysfunction, and most notably sudden cardiac death …

Abstract Background FDG PET/CT with myocardial perfusion imaging is a useful method for
evaluating cardiac sarcoidosis (CS), but interpretation is not standardized. We developed a …